In addition, therapy with altered PLGA-MOR-CTX nanoparticles led to increased caspase activation, cytoskeletal disruption, inhibition of MMP-2 action, and ROS production in the tumor tissue (Agarwal et al., 2019). Here, MMP2 is linked to neoplasm.